Browsing Clinical Inquiries, 2005 by Identifier "http://hdl.handle.net/10355/3291"
Now showing items 1-1 of 1
-
For those intolerant to ACE inhibitors and ARBs, what is the best therapy for reducing the risk of diabetic nephropathy?
(Family Physicians Inquiries Network, 2005)Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) are the first-line agents for reducing the risk of diabetic nephropathy. For patients intolerant to these agents, non-dihydropyridine ...